The F.D.A. and the powerful beverage industry protested the new findings, and a second W.H.O. group stood by its standard that the sweetener is generally safe.
Category: Food and Drug Administration
-
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
-
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
-
A.I. May Someday Work Medical Miracles. For Now, It Helps Do Paperwork.
For now, the best use for generative A.I. in health care is to ease the heavy burden of documentation that takes doctors hours a day and contributes to burnout.
-
An A.I. Diagnosis Can Wait. Just Eliminate ‘Pajama Time.’
For now, the best use for generative A.I. in health care is to ease the heavy burden of documentation that takes doctors hours a day and contributes to burnout.
-
How the Shortage of a $15 Cancer Drug Is Upending Treatment
Older generic chemotherapy drugs remain scarce, forcing doctors to put a priority on the patients who have the best chance of survival.
-
E-Cigarette Sales Soared During Pandemic Years
Flavors proliferated and disposable vapes took hold as purchases of vaping devices increased steadily from January 2020 to mid-2022.
-
FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant
An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.
-
Frozen Strawberries Recalled After Hepatitis A Infections
The F.D.A. urges checking freezers for the affected products sold at Walmart, Costco, Trader Joe’s and other retailers.
-
FDA Panel
A committee of experts voted in favor of a new shot administered to pregnant women, one in a series of new ways to arm the very young against a life-threatening virus.
-
Drug Shortages Near an All-Time High, Leading to Rationing
A worrisome scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are seeking ways to address widespread supply problems.